Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration.

Platelet endothelial cell adhesion molecule (PECAM)-1 has been implicated in angiogenesis, but a number of issues remain unsettled, including the independent involvement of human PECAM-1 (huPECAM-1) in tumor angiogenesis and the mechanisms of its participation in vessel formation. We report for tumors grown in human skin transplanted on severe combined immunodeficiency mice that antibodies against huPECAM-1 (without simultaneous treatment with anti-VE-cadherin antibody) decreased the density of human, but not murine, vessels associated with the tumors. Anti-huPECAM-1 antibody also inhibited tube formation by human umbilical vein endothelial cells (HUVEC) and the migration of HUVEC through Matrigel-coated filters or during the repair of wounded cell monolayers. The involvement of huPECAM-1 in these processes was confirmed by the finding that expression of huPECAM-1 in cellular transfectants induced tube formation and enhanced cell motility. These data provide evidence of a role for PECAM-1 in human tumor angiogenesis (independent of VE-cadherin) and suggest that during angiogenesis PECAM-1 participates in adhesive and/or signaling phenomena required for the motility of endothelial cells and/or their subsequent organization into vascular tubes.

[1]  L. Moreland.  Platelet-endothelial cell adhesion molecule-1 , 2004 .

[2]  C. Garlanda,et al.  Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice , 2004, Angiogenesis.

[3]  John,et al.  Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide. , 1995, Blood.

[4]  T. Mak,et al.  Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. , 2001, Blood.

[5]  P. Newman,et al.  Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. , 2001, Blood.

[6]  O. Majdic,et al.  Induction of Hyporesponsiveness and Impaired T Lymphocyte Activation by the CD31 Receptor:Ligand Pathway in T Cells1 , 2001, The Journal of Immunology.

[7]  P. Newman,et al.  Integrin Activation by Regulated Dimerization and Oligomerization of Platelet Endothelial Cell Adhesion Molecule (Pecam)-1 from within the Cell , 2001, The Journal of cell biology.

[8]  K. Wolff,et al.  Platelet endothelial cell adhesion molecule-1 and vascular endothelial cadherin cooperatively regulate fibroblast growth factor-induced modulations of adherens junction functions. , 2001, The Journal of investigative dermatology.

[9]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[10]  B. Engelhardt,et al.  PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis. , 2000, Molecular biology of the cell.

[11]  N. Ilan,et al.  Platelet-Endothelial Cell Adhesion Molecule-1 (CD31), a Scaffolding Molecule for Selected Catenin Family Members Whose Binding Is Mediated by Different Tyrosine and Serine/Threonine Phosphorylation* , 2000, The Journal of Biological Chemistry.

[12]  T. Mak,et al.  PECAM-1 (CD31) expression modulates bleeding time in vivo. , 2000, The American journal of pathology.

[13]  S. Nourshargh,et al.  Divergent Effects of Platelet-Endothelial Cell Adhesion Molecule-1 and β3 Integrin Blockade on Leukocyte Transmigration In Vivo1 , 2000, The Journal of Immunology.

[14]  S. Albelda,et al.  Contributions of the extracellular and cytoplasmic domains of platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) in regulating cell-cell localization. , 2000, Journal of cell science.

[15]  R. Wolthuis,et al.  The Small Gtpase, Rap1, Mediates Cd31-Induced Integrin Adhesion , 2000, The Journal of cell biology.

[16]  I. Gurubhagavatula,et al.  Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment1 , 2000, The Journal of Immunology.

[17]  É. Vivier,et al.  Immunoreceptor Tyrosine-based Inhibition Motifs , 2012, Current Topics in Microbiology and Immunology.

[18]  A. Poole,et al.  Thrombin‐induced association of SHP‐2 with multiple tyrosine‐phosphorylated proteins in human platelets , 1999, FEBS letters.

[19]  D. Rimm,et al.  PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. , 1999, Journal of cell science.

[20]  M. Gerritsen,et al.  Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. , 1999, The American journal of pathology.

[21]  Yoshiya Tanaka,et al.  Ligation of CD31 (PECAM-1) on Endothelial Cells Increases Adhesive Function of vβ3 Integrin and Enhances β1 Integrin-Mediated Adhesion of Eosinophils to Endothelial Cells , 1999 .

[22]  P. Newman,et al.  A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. , 1999, Journal of immunology.

[23]  M. Salmon,et al.  Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration. , 1999, Journal of cell science.

[24]  O. Blaschuk,et al.  N-cadherin-mediated human granulosa cell adhesion prevents apoptosis: a role in follicular atresia and luteolysis? , 1999, The American journal of pathology.

[25]  J. Lord,et al.  Differential association of cytoplasmic signalling molecules SHP‐1, SHP‐2, SHIP and phospholipase C‐γ1 with PECAM‐1/CD31 , 1999, FEBS letters.

[26]  P. Newman.  Switched at birth: a new family for PECAM-1. , 1999, The Journal of clinical investigation.

[27]  D. Rimm,et al.  PECAM-1 ( CD 31 ) functions as a reservoir for and a modulator of tyrosine-phosphorylated β-catenin , 1999 .

[28]  S. Chierchia,et al.  Functional Association of Platelet Endothelial Cell Adhesion Molecule-1 and Phosphoinositide 3-Kinase in Human Neutrophils* , 1998, The Journal of Biological Chemistry.

[29]  D. Jackson,et al.  Recruitment and Activation of SHP-1 Protein-tyrosine Phosphatase by Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) , 1998, The Journal of Biological Chemistry.

[30]  M. Corada,et al.  Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. , 1998, Journal of cell science.

[31]  N. Beauchemin,et al.  Regulation of Mouse PECAM-1 Tyrosine Phosphorylation by the Src and Csk Families of Protein-tyrosine Kinases* , 1998, The Journal of Biological Chemistry.

[32]  William A. Muller,et al.  Ligation of CD31/PECAM‐1 modulates the function of lymphocytes, monocytes and neutrophils , 1998, European journal of immunology.

[33]  G. Visentin,et al.  Cell Surface Glycosaminoglycans Do Not Serve as Ligands for PECAM-1 , 1998, The Journal of Biological Chemistry.

[34]  J. Madri,et al.  Platelet endothelial cell adhesion molecule-1 expression modulates endothelial cell migration in vitro. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[35]  D. Jackson,et al.  Platelet/endothelial cell adhesion molecule-1 serves as a costimulatory agonist receptor that modulates integrin-dependent adhesion and aggregation of human platelets. , 1998, Blood.

[36]  U. Dianzani,et al.  Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. , 1998, Journal of immunology.

[37]  D. Jackson,et al.  Characterization of Phosphotyrosine Binding Motifs in the Cytoplasmic Domain of Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Are Required for the Cellular Association and Activation of the Protein-tyrosine Phosphatase, SHP-2* , 1997, The Journal of Biological Chemistry.

[38]  H. DeLisser,et al.  Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras. , 1997, The American journal of pathology.

[39]  C. Garlanda,et al.  Involvement of endothelial PECAM-1/CD31 in angiogenesis. , 1997, The American journal of pathology.

[40]  H. DeLisser,et al.  Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1/CD31): A Multifunctional Vascular Cell Adhesion Molecule. , 1997, Trends in cardiovascular medicine.

[41]  N. Sheibani,et al.  Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis. , 1997, Molecular biology of the cell.

[42]  J. Madri,et al.  Platelet Endothelial Cell Adhesion Molecule-1 Is Phosphorylatable by c-Src, Binds Src-Src homology 2 Domain, and Exhibits Immunoreceptor Tyrosine-based Activation Motif-like Properties* , 1997, The Journal of Biological Chemistry.

[43]  B. Imhof,et al.  Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. , 1997, The American journal of pathology.

[44]  K. Wolff,et al.  Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. , 1997, Journal of immunology.

[45]  D. Jackson,et al.  The Protein-tyrosine Phosphatase SHP-2 Binds Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1) and Forms a Distinct Signaling Complex during Platelet Aggregation , 1997, The Journal of Biological Chemistry.

[46]  P. J. Newman,et al.  The biology of PECAM-1. , 1997, The Journal of clinical investigation.

[47]  J. Zahm,et al.  Fibronectin and its alpha 5 beta 1-integrin receptor are involved in the wound-repair process of airway epithelium. , 1996, The American journal of physiology.

[48]  J. Madri,et al.  Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Y. Iwamoto,et al.  A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo , 1996, International journal of cancer.

[50]  W. Knapp,et al.  Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses , 1996, The Journal of experimental medicine.

[51]  W. Muller,et al.  Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. , 1996, Journal of immunology.

[52]  E. Brown,et al.  Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1 , 1996 .

[53]  J. Zahm,et al.  Fibronectin and its α5β1-integrin receptor are involved in the wound-repair process of airway epithelium , 1996 .

[54]  E. Brown,et al.  Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1 , 1996 .

[55]  R. Pardi,et al.  The platelet endothelial cell adhesion molecule‐1 (PECAM1) contributes to endothelial barrier function , 1995, FEBS letters.

[56]  F. Sarkar,et al.  Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.

[57]  C. Uherek,et al.  CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium , 1995, The Journal of cell biology.

[58]  J. Sun,et al.  IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. , 1995, Journal of immunology.

[59]  E. Butcher,et al.  Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide. , 1995, Blood.

[60]  W. Muller,et al.  Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). , 1995, Journal of immunology.

[61]  C. Ura,et al.  CD 31 / PECAM-1 Is a Ligand for otv 133 Integrin Involved in Adhesion of Leukocytes to Endothelium , 2002 .

[62]  J. Oliver,et al.  Signals from platelet/endothelial cell adhesion molecule enhance the adhesive activity of the very late antigen-4 integrin of human CD34+ hemopoietic progenitor cells. , 1994, Journal of immunology.

[63]  C. Mickanin,et al.  Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. , 1994, Development.

[64]  G. H. Nelson,et al.  Anti-CD31 delays platelet adhesion/aggregation at sites of endothelial injury in mouse cerebral arterioles. , 1994, The American journal of pathology.

[65]  B. Davidson,et al.  Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. , 1994, Cancer research.

[66]  W. Muller,et al.  Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo , 1994, The Journal of experimental medicine.

[67]  S. Thom,et al.  Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. , 1993, Science.

[68]  A. Hatzfeld,et al.  The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. , 1993, Blood.

[69]  S. Albelda,et al.  Murine platelet endothelial cell adhesion molecule (PECAM‐1)/CD31 modulates β2 integrins on lymphokine‐activated killer cells , 1993, European journal of immunology.

[70]  H. DeLisser,et al.  Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. , 1993, The Journal of biological chemistry.

[71]  Frans,et al.  Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene , 1993, The Journal of cell biology.

[72]  S. Albelda,et al.  Platelet endothelial cell adhesion molecule, PECAM‐1, modulates cell migration , 1992, Journal of cellular physiology.

[73]  M. Takeichi,et al.  Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts , 1992, The Journal of cell biology.

[74]  Y. Tanaka,et al.  CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion , 1992, The Journal of experimental medicine.

[75]  L. Romer,et al.  EndoCAM: a novel endothelial cell-cell adhesion molecule , 1990, The Journal of cell biology.